From my colleague Elaine Chen: Wave Life Sciences said today that interim data show its investigational siRNA therapy cut ...

Evaxion Biotech AS (NASDAQ:EVAX) climbed 4.2% in Monday’s premarket session after sharing new preclinical data supporting its ...

Sartorius Group is expected to continue delivering high-single digit CER sales growth in 2026, supported by strong consumables performance. JPMorgan maintains an Overweight rating with price targets ...

Minogue’s cash infusion over the past two months exceeds fundraising by his Republican rivals, and tops the more than $2.8 ...

Convergen, a biotech company pioneering targeted protein degradation (TPD) therapies for diseases driven by pathological protein aggregates, today announced the closing of a $10 million Seed financing ...

The Symbol of National Quality (SNQ), initiated by Taiwan’s Institute for Biotechnology and Medicine Industry (IBMI), has partnered with the International Consortium for Health Outcomes Measurement ...

Individuals with type 1 diabetes (T1D) and type 2 diabetes (T2D) have increased incidence rates of sudden cardiac death (SCD) compared with the general population, according to a study published ...

March Bio is continuing enrollment in the Phase 2 trial, with the Independent Data Monitoring Committee’s approval to advance to Simon Stage 2 of the Phase 2 trial. The Company anticipates presenting ...

Multinational fresh food grower and distributor Camposol opened the doors of its new biofactory in Peru. The company says the ...

Shares of Structure Therapeutics surged Monday after the biotechnology company said an experimental pill helped people lose substantial weight in a mid-stage clinical trial. The shares more than ...

Excell Partners CEO Theresa Mazzullo will retire in January after nearly 20 years, passing leadership to COO Rami Katz. Under Mazzullo, Excell grew from a $2M seed fund to $80M and launched the ...

Physician and science communicator Kristen Panthagani talks about why public trust in vaccines has fallen since the COVID-19 ...